| Thyroid cancer stem-like cell exosomes: regulation of EMT via transfer of lncRNAs H Hardin, H Helein, K Meyer, S Robertson, R Zhang, W Zhong, RV Lloyd Laboratory Investigation 98 (9), 1133-1142, 2018 | 114 | 2018 |
| Expression of epithelial-mesenchymal transition regulators SNAI2 and TWIST1 in thyroid carcinomas D Buehler, H Hardin, W Shan, C Montemayor-Garcia, PS Rush, S Asioli, ... Modern Pathology 26 (1), 54-61, 2013 | 101 | 2013 |
| Inhibition of adenine nucleotide translocator pore function and protection against apoptosis in vivo by an HIV protease inhibitor JGR Weaver, A Tarze, TC Moffat, M LeBras, A Deniaud, C Brenner, ... The Journal of clinical investigation 115 (7), 1828-1838, 2005 | 101 | 2005 |
| The roles of the epithelial-mesenchymal transition marker PRRX1 and miR-146b-5p in papillary thyroid carcinoma progression H Hardin, Z Guo, W Shan, C Montemayor-Garcia, S Asioli, XM Yu, ... The American journal of pathology 184 (8), 2342-2354, 2014 | 100 | 2014 |
| The role of epithelial mesenchymal transition markers in thyroid carcinoma progression C Montemayor-Garcia, H Hardin, Z Guo, C Larrain, D Buehler, S Asioli, ... Endocrine pathology 24, 206-212, 2013 | 76 | 2013 |
| Cancer stem-like cells and thyroid cancer Z Guo, H Hardin, RV Lloyd Endocrine-Related Cancer 21 (5), T285-T300, 2014 | 67 | 2014 |
| The evolving concept of cancer stem-like cells in thyroid cancer and other solid tumors H Hardin, R Zhang, H Helein, D Buehler, Z Guo, RV Lloyd Laboratory Investigation 97 (10), 1142-1151, 2017 | 63 | 2017 |
| Non-coding RNAs in thyroid cancer R Zhang, H Hardin, J Chen, Z Guo, RV Lloyd Endocrine pathology 27, 12-20, 2016 | 63 | 2016 |
| MALAT1 long non-coding RNA expression in thyroid tissues: analysis by in situ hybridization and real-time PCR R Zhang, H Hardin, W Huang, J Chen, S Asioli, A Righi, F Maletta, ... Endocrine pathology 28, 7-12, 2017 | 56 | 2017 |
| MicroRNA-21 and long non-coding RNA MALAT1 are overexpressed markers in medullary thyroid carcinoma YH Chu, H Hardin, DF Schneider, H Chen, RV Lloyd Experimental and molecular pathology 103 (2), 229-236, 2017 | 55 | 2017 |
| In situ hybridization analysis of miR-146b-5p and miR-21 in thyroid nodules: diagnostic implications Z Guo, H Hardin, C Montemayor-Garcia, S Asioli, A Righi, F Maletta, ... Endocrine pathology 26, 157-163, 2015 | 53 | 2015 |
| A high throughput in situ hybridization method to characterize mRNA expression patterns in the fetal mouse lower urogenital tract LL Abler, V Mehta, KP Keil, PS Joshi, CL Flucus, HA Hardin, CT Schmitz, ... JoVE (Journal of Visualized Experiments), e2912, 2011 | 50 | 2011 |
| Thyroid cancer stem-like cells and epithelial-mesenchymal transition in thyroid cancers H Hardin, C Montemayor-Garcia, RV Lloyd Human pathology 44 (9), 1707-1713, 2013 | 43 | 2013 |
| Long non-coding RNA Linc-ROR is upregulated in papillary thyroid carcinoma R Zhang, H Hardin, W Huang, D Buehler, RV Lloyd Endocrine pathology 29, 1-8, 2018 | 40 | 2018 |
| Dioxin causes ventral prostate agenesis by disrupting dorsoventral patterning in developing mouse prostate CM Vezina, SH Allgeier, RW Moore, TM Lin, JC Bemis, HA Hardin, ... Toxicological sciences 106 (2), 488-496, 2008 | 39 | 2008 |
| Stem cells and cancer stem-like cells in endocrine tissues RV Lloyd, H Hardin, C Montemayor-Garcia, F Rotondo, LV Syro, ... Endocrine pathology 24, 1-10, 2013 | 36 | 2013 |
| Generation of novel thyroid cancer stem-like cell clones: effects of resveratrol and valproic acid H Hardin, XM Yu, AD Harrison, C Larrain, R Zhang, J Chen, H Chen, ... The American Journal of Pathology 186 (6), 1662-1673, 2016 | 32 | 2016 |
| Targeting autophagy in thyroid cancers W Wei, H Hardin, QY Luo Endocrine-related cancer 26 (4), R181-R194, 2019 | 26 | 2019 |
| AKT activity is elevated in aggressive thyroid neoplasms where it promotes proliferation and invasion DR Matson, H Hardin, D Buehler, RV Lloyd Experimental and Molecular Pathology 103 (3), 288-293, 2017 | 26 | 2017 |
| Parathyroid neoplasms: immunohistochemical characterization and long noncoding RNA (lncRNA) expression Q Yu, H Hardin, YH Chu, W Rehrauer, RV Lloyd Endocrine Pathology 30, 96-105, 2019 | 24 | 2019 |
sofia asioliUniversità di BolognaE-mail megerősítve itt: unibo.it
